Format

Send to

Choose Destination
Cancer Discov. 2019 Feb;9(2):303. doi: 10.1158/2159-8290.CD-18-1515.

Correction: An Acquired HER2 T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer.

PMID:
30737217
DOI:
10.1158/2159-8290.CD-18-1515
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center